Welcome to the Prorada podcast, the podcast that takes 10 minutes to get you smarter on the collision of tech, business, and politics.

Sponsored by TSX Broadway. Filling in for Dan Primack, I'm Kim Hart. On today's show, another casualty of the government shutdown, and a self-driving car startup is getting a big infusion of cash.

But first, Amazon is becoming more of a regulatory target, but not for the reason you might expect.

Amazon has expanded rapidly into new business areas, like its foray into groceries

with its purchase of whole foods.

But what has some regulators worried is Amazon's own private label products, like Amazon

basics, which are in-house versions of the goods that other manufacturers already sell

on Amazon.com.

In fact, Amazon currently has 135 generic brands and

has deals to sell at least twice that many brands exclusively around the world. Critics argue

Amazon uses its vast sales data to find opportunities where it can produce generic versions of

already popular products. And some policymakers say the concern comes when Amazon owns both the

platform for selling products as well

as the competing brand to those products. In 15 seconds, we'll take a closer look at this with

Axios tech reporter David McCabe. But first, this. Imagine watching your favorite performer live

from one of the most highly traffic corners of the United States, Times Square. Now imagine watching

it against a 46-story tower

that has full-building LED lighting and the highest resolution 18,000 square foot podium sign in

Times Square. TSX Broadway is making this dream a reality. Visit TSXBroadway.com for an inside look

at the future.

Joining us in the studio now is tech policy reporter David McCabe.

This emerging squabble between Amazon and regulators isn't just about the company expanding the things it sells. It's really about the fact that Amazon is increasingly

...